Pharmacy update : The future of warfarin dosing : what is in the pipeline?

dc.contributor.author	Bird, Joshua	eng
dc.contributor.author	Vyas, Deepti	eng
dc.date.issued	2009-01	eng
dc.description.abstract	Pharmacogenetic testing has been researched to find genetic variability among individuals who require warfarin therapy and to possibly reduce the occurrence of adverse events.	eng
dc.description.bibref	Includes bibliographical references	eng
dc.format.extent	2 pages	eng
dc.identifier.uri	https://hdl.handle.net/10355/61700
dc.language	English	eng
dc.publisher	University of Missouri, Department of Medicine, Division of Hospital Medicine	eng
dc.relation.ispartof	Missouri hospitalist, issue 13 (2009 January 15)	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
dc.source	Harvested from the American Journal of Hospital Medicine website (http://medicine2.missouri.edu/jahm/) in 2018.	eng
dc.subject	Coumadin, pharmacogenetic testing, genetic variability, variant alleles	eng
dc.title	Pharmacy update : The future of warfarin dosing : what is in the pipeline?	eng
dc.type	Article	eng